Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
2.
Oncology Research and Treatment ; 45(Supplement 3):43, 2022.
Article in English | EMBASE | ID: covidwho-2214115

ABSTRACT

Background: Due to covid-19 pandemic, the lock downs and long homeschooling periods children /adolescents and their parents were neither reachable for school personnel nor for healthcare professionals. Therefore, vaccination rates decreased by 14% for girls and 9% for boys (DAK Kinderund Jugendreport 2021). Consequently, children in the target age of 9 to 14 years were lost for the HPV-vaccination. A 2-dose-vaccination-scheme is used for children younger than 15 years. Older kids need 3 vaccinations for a complete immunization. The GKV generally reimburses only the cost for age groups younger than 18 years. We aim to assess the resulting HPV associated treatment cost in the German healthcare system and to develop a proposal on how to get the lost cohorts vaccinated. Method(s): To assess the additional cost related to the decrease in vaccination rates, we plan to use the following approaches: Scenarios analysis of the need of the 3-dose-scheme (Vaccine, organization, personnel) and future HPV related treatment costs. We will conduct expert interviews and compare sales figures of Gardasil with data from the KV. Finally, we compare European / international countries, on how do they organize the catch-up for the lost cohorts. Result(s): We expect increasing costs due to a third vaccination regime and the treatment of HPV related cancers based on missing immunizations in the juvenile age. Discussion(s): An increased financial burden will be result in the future, if Germany fails to catch-up the lost children and adolescents based on the HPV vaccination gap due to the pandemic. Mechanisms need to be in place to include adolescents, i.e. through the J1-exami, for the catch-up vaccinations. Alternatively, the age limit for a reimbursement could be raised for a limited period of time to immunize the young adults between 18 and 20 years. In collaboration with the Allianz gegen HPV.

3.
Acta Physiologica Conference: 5th Congress of Physiology and Integrative Biology and 89th Congress of French Physiological Society Lyon France ; 236(Supplement 726), 2022.
Article in English | EMBASE | ID: covidwho-2192376

ABSTRACT

Introduction: Wearing a mask is one of the least costly measures for containing the spread of the Covid-19. This is one of the protective measures put in place by the coordinating team of the inter-university diploma on Antibiology and Antibiotic Therapy in Sub-Saharan Africa for its 2021 session. The objective of our study was to evaluate the acceptability of wearing a mask by health personnel from sub-Saharan Africa during the 05-week training course. Method(s): A descriptive cross-sectional study was conducted from July 15 to November 15, 2021. The survey was the study method, using individual interview and observation as study techniques. During the individual interview it was administered a semi-structured questionnaire including the aspects related to observation. Result(s): A total of 58 people were interviewed (35 +/- 0.83 years, 75.86% males). The most represented professions were medical specialists 31.03%, biologists 29.31% and general practitioners 18.27%. 56.90% of the participants wore the mask systematically, 34.48% wore it often with an average of 7 h24 of daily wear and 58.6% respected the instructions on the proper use of masks. The main inconvenience of wearing the mask was the problem of comfort for 46.55%. For 12.07%, the respiratory history (asthma, pneumonia, tuberculosis) contributed to the discomfort of wearing the mask, with respiratory difficulty being the discomfort felt. Conclusion(s): The wearing of masks during the 5-week training in the context of Covid-19 is globally accepted by the health personnel. The health personnel have a fairly good knowledge of the interest of this measure.

SELECTION OF CITATIONS
SEARCH DETAIL